3/20/2007

Some top scientists are questioning the wisdom of the NIH's Cancer Genome Atlas, an effort to identify mutations in cancer cells. The project could divert money from more important research and its basic premise may be flawed, the scientists say.

Full Story:
MSNBC

Related Summaries